Absci Corporation
Organization details
- Legal name
- Absci Corporation
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 8731 — Services-Commercial Physical & Biological Research
- Headquarters city
- Vancouver
- Headquarters state / province
- Washington
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ABSI
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001672688
- EIN
- 85-3383487
Board of directors
-
Amrit Nagpal · DirectorSince 2023
-
Daniel A. Rabinovitsj · DirectorSince 2023
-
Frans Van Houten · DirectorSince 2023
-
Jeremy Green · DirectorSince 2023
-
Joseph Sirosh · DirectorSince 2023
-
Karen K. Mcginnis · DirectorSince 2023
-
Mary T. Szela · DirectorSince 2025
-
Menelas N. Pangalos · DirectorSince 2024
-
Sean McClain · Director · Chief Executive OfficerSince 2023
-
Zachariah Jonasson · Director · CFO / CBOSince 2023
Chief executives
Director election results
Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
83.4%
Board connections
4 of this board's directors also sit on 9 other boards. 8 are in the same sector.
-
Alphatec Holdings Inc. Same sectorvia Karen K. Mcginnis
-
Atara Biotherapeutics Inc. Same sectorvia Jeremy Green
- via Mary T. Szela
-
Biogen Inc. Same sectorvia Menelas N. Pangalos
-
Fate Therapeutics Inc. Same sectorvia Jeremy Green
-
Kura Oncology Inc. Same sectorvia Mary T. Szela
-
Shattuck Labs Inc. Same sectorvia Jeremy Green
-
TriSalus Life Sciences Inc. Same sectorvia Mary T. Szela
-
iRhythm Holdings Inc. Same sectorvia Karen K. Mcginnis
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $933,174
- 5 purchases by 4 insiders
- Sold, last 12 months
- $132,328
- 2 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 29, 2026 | Sean McClain Director, Officer (Chief Executive Officer) | Shares withheld for tax | −79,860 | $12.10 | $966,306 |
| Aug 31, 2026 | Zachariah Jonasson Officer (CFO / CBO) | Shares withheld for tax | −8,320 | $8.71 | $72,467 |
| Jun 30, 2026 | Mary T. Szela Director | Open-market purchase | +12,900 | $11.54 | $148,866 |
| Jun 24, 2026 | Sean McClain Director, Officer (Chief Executive Officer) | Shares withheld for tax | −59,896 | $10.08 | $603,752 |
| Jun 4, 2026 | Karen K. Mcginnis Director | Grant or award | +10,100 | — | — |
| Jun 4, 2026 | Mary T. Szela Director | Grant or award | +10,100 | — | — |
| Jun 4, 2026 | Menelas N. Pangalos Director | Grant or award | +10,100 | — | — |
| Jun 4, 2026 | Frans Van Houten Director | Grant or award | +10,100 | — | — |
| Jun 4, 2026 | Daniel A. Rabinovitsj Director | Grant or award | +10,100 | — | — |
| Jun 4, 2026 | Joseph Sirosh Director | Grant or award | +10,100 | — | — |
| May 31, 2026 | Zachariah Jonasson Officer (CFO / CBO) | Shares withheld for tax | −8,319 | $6.75 | $56,153 |
| May 13, 2026 | Menelas N. Pangalos Director | Open-market purchase | +37,453 | $5.36 | $200,748 |
| Mar 12, 2026 | Busch Andreas Officer (Chief Innovation Officer) | Open-market purchase | +100,000 | $2.29 | $229,000 |
| Mar 3, 2026 | Busch Andreas Officer (Chief Innovation Officer) | Shares withheld for tax | −1,257 | $2.80 | $3,520 |
| Mar 3, 2026 | Walker Shelby J. Officer (Chief Legal Officer) | Shares withheld for tax | −9,825 | $2.80 | $27,510 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Absci Corporation
Who is the CEO of Absci Corporation?
Sean McClain is Absci Corporation's Chief Executive Officer.
How many directors are on Absci Corporation's board?
Absci Corporation's board has 10 directors: Amrit Nagpal, Daniel A. Rabinovitsj, Frans Van Houten, Jeremy Green, Joseph Sirosh, Karen K. Mcginnis, Mary T. Szela, Menelas N. Pangalos, Sean McClain and Zachariah Jonasson.
Are Absci Corporation insiders buying or selling shares?
Over the last 12 months, Absci Corporation insiders bought $933,174 of shares in 5 purchases and sold $132,328 of shares in 2 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="absci-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.